Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phosphorated carbohydrate solution is an over-the-counter antiemetic medication used to relieve nausea and vomiting associated with upset stomach, intestinal flu, and food or drink indiscretions. It is a hyperosmolar solution containing dextrose (glucose), levulose (fructose), and phosphoric acid. The drug works by exerting a direct effect on the gastrointestinal tract wall, reducing the rate of gastric emptying and the contraction of GI smooth muscle. Unlike systemic antiemetics, it acts locally and does not contain alcohol, caffeine, or antihistamines, making it a common choice for treating nausea during pregnancy. It is currently manufactured by WellSpring Pharmaceutical Corporation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on phosphorated carbohydrate solution.